Print this page    •   Back to Web version of article

Effectiveness of the Direct Observation Component of DOTS for Tuberculosis: a Randomized Controlled Trial in Pakistan

March 15, 2001

In an effort to assess the efficacy of various tuberculosis (TB) treatment packages in Pakistan, researchers studied nearly 500 adults with new sputum-positive TB. Of the 497 adults, 170 were put into a directly observed therapy, short-course (DOTS) treatment program with observation by health workers, 165 were put into DOTS program requiring a family member observe the treatment, and 162 were assigned self-administered treatment. The trial was conducted at three different clinical sites that provided World Health Organization-sanctioned TB services that included a standard daily, short-course, eight-month drug therapy program. The researchers found that within the safety net of the service clinics, all the DOTS programs, regardless of observation, type gave similar outcomes. The patient cure rate using the DOT health worker observation component was 64 percent, while the rate for the group using family observation was 55 percent and self-administered treatment was 62 percent. According to the authors, none of the three strategies appear to be superior over the other, and they noted that direct observation of treatment did not further boost cure rates.


Other CDC News for March 15, 2001

Effectiveness of the Direct Observation Component of DOTS for Tuberculosis: a Randomized Controlled Trial in Pakistan

Maker Yielding Patent in Africa for AIDS Drug

Antiviral Cocktails Cut Cost of Treating Patients With HIV

South Africa Resists Call for AIDS Emergency
As AIDS Grows For Minorities, So Does Funding; Groups Assisting City's Blacks, Latinos Win Increased Support

The Danger of Living "Down Low"; Black Men Who Hide Their Bisexuality Can Put Women at Risk

A New AIDS Strategy

Brazil to Launch AIDS Vaccine Human Trials in April
Mogae Warns Botswana Faces Extinction From AIDS


Previous Updates

Excerpted from:
Lancet (www.thelancet.com)
03/03/01; Vol. 357, No. 9257, P. 664; Walley, John D.; Khan, M. Amir; Newell, James N.; et al.




This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art19956.html

General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.